LIFESTYLE AND ANTHROPOMETRIC PARAMETERS IN PATIENTS WITH NONFUNCTIONAL ADRENAL INCIDENTALOMAS

Overview

Journal Acta Endocrinol (Buchar)

Specialty Endocrinology

Date 2023 Aug 21

PMID 37601721

Authors

A N Dagdemir

A Akalin

Affiliations

Soon will be listed here.

Abstract

Objective: We aimed to investigate whether lifestyle and body fat mass have an impact on the occurence of nonfunctional adrenal incidentalomas (NFAI).

Methods: 100 patients with NFAI were included . 50 people constituted the control group. Physical activities of these groups were evaluated (using the International Physical Activity Questionnaire), smoking status was determined, anthropometric measurements were made. Body fat mass, fat percentage, total body water and fat free mass were measured using bioelectrical impedance method.

Results: Body mass index (BMI), waist, hip, neck circumference, total body fat percentage and fat mass and smoking rate were found to be statistically higher in the patient group. Physical activities did not differ significantly. When a subgroup with similar age and BMI among was created, waist circumference and total fat mass were again significantly higher in the patient group. There was a significant positive correlation between the size of the adrenal mass and waist, neck circumference, BMI, and cortisol after 1 mg dexamethasone suppression test.

Conclusion: The increase in the fat mass may have an impact on the development of NFAI. Although the patients were regarded as nonfunctional, suppressibility of the cortisol decreases as the mass size of the incidentaloma increases.

Citing Articles

Relationship of obesity, body fat, benign adrenal tumors and the mediating mechanism: a two-step mendelian randomization study.

Wang Q, Lv D, Wen J, Zhou H, Jia M, Li J BMC Cancer. 2025; 25(1):360.

PMID: 40016652 PMC: 11866879. DOI: 10.1186/s12885-025-13774-0.

Cardiometabolic comorbidities and cardiovascular events in "non-functioning" adrenal incidentalomas: a systematic review and meta-analysis.

Favero V, Parazzoli C, Bernasconi D, Chiodini I J Endocrinol Invest. 2024; 47(12):2929-2942.

PMID: 39347906 PMC: 11549128. DOI: 10.1007/s40618-024-02440-0.

References

Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N . Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clin Endocrinol (Oxf). 1998; 49(2):165-71. DOI: 10.1046/j.1365-2265.1998.00509.x. View

Yilmaz N, Tazegul G, Sari R, Avsar E, Altunbas H, Balci M . EFFECTIVENESS OF UNILATERAL ADRENALECTOMY IN BILATERAL ADRENAL INCIDENTALOMA PATIENTS WITH SUBCLINICAL HYPERCORTISOLEMIA. Acta Endocrinol (Buchar). 2022; 17(4):479-485. PMC: 9206144. DOI: 10.4183/aeb.2021.479. View

Garrapa G, Pantanetti P, Arnaldi G, Mantero F, Faloia E . Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. J Clin Endocrinol Metab. 2001; 86(11):5301-6. DOI: 10.1210/jcem.86.11.8059. View

Arduc A, Isik S, Ozuguz U, Tutuncu Y, Kucukler F, Ozcan H . Relationship between thyroid nodules and non-functioning adrenal incidentalomas and their association with insulin resistance. Endocr Res. 2013; 39(3):99-104. DOI: 10.3109/07435800.2013.840653. View

Tuna M, NasiroglU Imga N, Dogan B, Yilmaz F, Topcuoglu C, Akbaba G . Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis. J Endocrinol Invest. 2014; 37(8):765-768. DOI: 10.1007/s40618-014-0106-5. View

Craig C, Marshall A, Sjostrom M, Bauman A, Booth M, Ainsworth B . International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003; 35(8):1381-95. DOI: 10.1249/01.MSS.0000078924.61453.FB. View

Saglam M, Arikan H, Savci S, Inal-Ince D, Bosnak-Guclu M, Karabulut E . International physical activity questionnaire: reliability and validity of the Turkish version. Percept Mot Skills. 2010; 111(1):278-84. DOI: 10.2466/06.08.PMS.111.4.278-284. View

Peppa M, Boutati E, Koliaki C, Papaefstathiou N, Garoflos E, Economopoulos T . Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?. Metabolism. 2010; 59(10):1435-41. DOI: 10.1016/j.metabol.2010.01.007. View

Wagnerova H, Dudasova D, Lazurova I . Hormonal and metabolic evaluation of adrenal incidentalomas. Neoplasma. 2009; 56(6):521-5. DOI: 10.4149/neo_2009_06_521. View

10.

Baulieu E, Robel P . Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci U S A. 1998; 95(8):4089-91. PMC: 34265. DOI: 10.1073/pnas.95.8.4089. View

11.

Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M . Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab. 1999; 84(2):520-6. DOI: 10.1210/jcem.84.2.5444. View

12.

Mantero F, Terzolo M, Arnaldi G, Osella G, Masini A, Ali A . A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000; 85(2):637-44. DOI: 10.1210/jcem.85.2.6372. View

13.

Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A . Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016; 175(2):G1-G34. DOI: 10.1530/EJE-16-0467. View

14.

Fernandez-Real J, Engel W, Simo R, Salinas I, Webb S . Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma. Clin Endocrinol (Oxf). 1998; 49(1):53-61. DOI: 10.1046/j.1365-2265.1998.00437.x. View

15.

Prager G, Heinz-Peer G, Passler C, Kaczirek K, Schindl M, Scheuba C . Surgical strategy in adrenal masses. Eur J Radiol. 2001; 41(1):70-7. DOI: 10.1016/s0720-048x(01)00441-7. View

16.

Grumbach M, Biller B, Braunstein G, Campbell K, Carney J, Godley P . Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med. 2003; 138(5):424-9. DOI: 10.7326/0003-4819-138-5-200303040-00013. View

17.

Terzolo M, Pia A, Ali A, Osella G, Reimondo G, Bovio S . Adrenal incidentaloma: a new cause of the metabolic syndrome?. J Clin Endocrinol Metab. 2002; 87(3):998-1003. DOI: 10.1210/jcem.87.3.8277. View

18.

Kloos R, Gross M, Francis I, Korobkin M, Shapiro B . Incidentally discovered adrenal masses. Endocr Rev. 1995; 16(4):460-84. DOI: 10.1210/edrv-16-4-460. View